
Loading, please wait...

Loading, please wait...

The Ket-BD randomized clinical trial evaluated adjunctive intravenous ketamine in adults with treatment-resistant bipolar I or II depression who had failed at least 2 evidence-based pharmacotherapies. Sixty-eight participants were randomized 1:1 to four flexibly dosed ketamine infusions (0.5–0.75 mg/kg) or midazolam over 2 weeks, with 63 included in the final efficacy analysis. At day 14, mean MADRS scores were significantly lower with ketamine, with a between-group difference of −7.3 points (95% CI, −12.0 to −2.5; P=.003; Cohen d=0.7). No cases of mania, hypomania, psychosis, or suicide attempts occurred in either group; one participant in each group developed mixed features.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Ket-BD randomized clinical trial evaluated adjunctive intravenous ketamine in adults with treatment-resistant bipolar I or II depression who had failed at least 2 evidence-based pharmacotherapies. Sixty-eight participants were randomized 1:1 to four flexibly dosed ketamine infusions (0.5–0.75 mg/kg) or midazolam over 2 weeks, with 63 included in the final efficacy analysis. At day 14, mean MADRS scores were significantly lower with ketamine, with a between-group difference of −7.3 points (95% CI, −12.0 to −2.5; P=.003; Cohen d=0.7). No cases of mania, hypomania, psychosis, or suicide attempts occurred in either group; one participant in each group developed mixed features.
2 months ago

A multicenter study validates a machine learning-guided recalibrated SOFA score, demonstrating significantly improved ICU mortality discrimination while preserving the simple, additive, point-based structure critical for bedside decision-making.
Yesterday

A landmark study reveals that lipid-rich malignant ascites alters the T-cell metabolic transcriptome, causing cholesterol efflux and impaired fatty acid oxidation. This suppresses TCR signalling and blocks BiTE immunotherapy, while lipid depletion restores antitumour cytotoxicity in ovarian cancer.
Yesterday

Researchers have engineered novel light-on photoswitchable adrenoceptor agonists targeting β1-receptors. By remaining inactive until illuminated, these precision molecules offer reversible optical control, tailored relaxation kinetics, and distinct efficacy profiles, paving the way for targeted cardiovascular therapies.
2 days back

A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 weeks back

This review examines the pharmacogenomics of antidiabetic agents, highlighting how genetic variations in SLC2A2, SLC47A1, CYP2C9, ABCC8, and GLP1R influence drug transport, therapeutic efficacy, and hypoglycemia risk to enable tailored precision medicine in type 2 diabetes.
Yesterday